Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Gilead Sciences ( (GILD) ) has issued an update.
On May 20, 2026, Gilead Sciences entered into an eleventh supplemental indenture with Computershare Trust Company to support a new multi‑tranche debt issuance totaling $3 billion in senior notes, with maturities in 2028, 2029, 2031 and 2034 and coupon rates ranging from 4.250% to 4.900%, sold via a public offering. The notes, which include change‑of‑control repurchase obligations, limits on secured indebtedness and sale‑leaseback transactions, and optional redemption features, provide Gilead with additional financial flexibility for general corporate purposes, including potential acquisitions and strategic deals, while adding structured leverage that stakeholders will monitor for its impact on the company’s balance sheet and strategic capacity.
The most recent analyst rating on (GILD) stock is a Buy with a $165.00 price target. To see the full list of analyst forecasts on Gilead Sciences stock, see the GILD Stock Forecast page.
Spark’s Take on GILD Stock
According to Spark, TipRanks’ AI Analyst, GILD is a Outperform.
Score is driven primarily by strong financial performance (high margins, solid free cash flow, and improved leverage) and a positive earnings update with raised guidance and strong HIV/oncology momentum. The rating is moderated by weak near-term technical momentum and near-term headline EPS/tax distortion from large acquisition-related charges, while valuation is reasonable but not notably discounted.
To see Spark’s full report on GILD stock, click here.
More about Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company focused on researching, developing and commercializing medicines, particularly in areas such as antiviral and other serious diseases. The company accesses capital markets through public debt offerings to support general corporate purposes, including acquisitions, investments and other strategic transactions.
Average Trading Volume: 6,128,363
Technical Sentiment Signal: Buy
Current Market Cap: $161B
For an in-depth examination of GILD stock, go to TipRanks’ Overview page.